cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Marinus Pharmaceuticals Inc
2 own
17 watching
Current Price
$6.71
$0.22
(3.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
249.59M
52-Week High
52-Week High
12.37
52-Week Low
52-Week Low
3.465
Average Volume
Average Volume
1.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization249.59M
icon52-Week High12.37
icon52-Week Low3.465
iconAverage Volume1.05M
iconDividend Yield--
iconP/E Ratio--
What does the Marinus Pharmaceuticals Inc do?
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company s ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.
Read More
How much money does Marinus Pharmaceuticals Inc make?
News & Events about Marinus Pharmaceuticals Inc.
Business Wire
3 months ago
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the pricing of its underwritten public offering of 10,526,316 shares of its common stock at a public offering price of $4.75 per...
Business Wire
3 months ago
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has entered into a revenue interest financing agreement with Sagard Healthcare Partners for a total of $32.5 million...
Business Wire
6 months ago
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to seven new employees. The Compensation Committee of the Board of Directors of Marinus approved...
Business Wire
8 months ago
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that management will participate in the following investor and medical conferences in May and June: Citi Biotech Virtual...
Frequently Asked Questions
Frequently Asked Questions
What is Marinus Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Marinus Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Marinus Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Marinus Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Marinus Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Marinus Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Marinus Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Marinus Pharmaceuticals Inc?
plus_minus_icon
What percentage is Marinus Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Marinus Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$6.71
$0.22
(3.39%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00